{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:31:18Z","timestamp":1793370678715,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012852","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000}}],"reference-count":148,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012852.pub2","type":"journal-article","created":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T08:56:39Z","timestamp":1588409799000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss"],"prefix":"10.1002","volume":"2020","author":[{"given":"Eva N","family":"Hamuly\u00e1k","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luuk JJ","family":"Scheres","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauritia C","family":"Marijnen","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00ebtte","family":"Goddijn","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Department of Obstetrics and Gynaecology; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Middeldorp","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,5,2]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD012852.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00404-011-2055-y","article-title":"Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipid antibody syndrome","volume":"285","author":"Alalaf","year":"2012","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"6","key":"10.1002\/14651858.CD012852.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"e12770","DOI":"10.1111\/aji.12770","article-title":"Use of d-dimer measurement to guide anticoagulant treatment in recurrent pregnancy loss associated with antiphospholipid syndrome","volume":"78","author":"Bao","year":"2017","journal-title":"American Journal of Reproductive Immunology"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0003|cit3","unstructured":"Farquharson R Antiphospholipid syndrome in pregnancy: a controlled treatment trial www.isrctn.com\/ISRCTN55179279"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006250-200212000-00032","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0005|cit5","first-page":"S22","article-title":"Antiphospholipid syndrome in pregnancy: a controlled treatment trial","volume":"21 Suppl 1","author":"Farquharson","year":"2001","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"8","key":"10.1002\/14651858.CD012852.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3109\/01443615.2010.518651","article-title":"Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome","volume":"30","author":"Fouda","year":"2010","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD012852.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijgo.2010.09.010","article-title":"Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome","volume":"112","author":"Fouda","year":"2011","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0008|cit8","unstructured":"Low-molecular-weight heparin (LMWH) versus unfractionated heparin (UFH) in pregnant women with history of recurrent abortion secondary to antiphospholipid syndrome clinicaltrials.gov\/ct2\/show\/results\/NCT01051778"},{"issue":"5","key":"10.1002\/14651858.CD012852.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0897.1996.tb00501.x","article-title":"A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin","volume":"35","author":"Kutteh","year":"1996","journal-title":"American Journal of Reproductive Immunology"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0011|cit11","unstructured":"Laskin CA A randomized controlled trial comparing low molecular weight heparin and aspirin to aspirin alone in women with unexplained recurrent pregnancy loss clinicaltrials.gov\/ct2\/show\/NCT00564174"},{"issue":"2","key":"10.1002\/14651858.CD012852.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1067\/mob.2000.106754","article-title":"Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial","volume":"183","author":"Pattison","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0014|cit14","first-page":"44","article-title":"Randomized trial of aspirin versus aspirin and heparin in pregnant women with the antiphospholipid syndrome","volume":"147 Suppl 1","author":"Cohen","year":"1996","journal-title":"Annales de Medecine Interne"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"issue":"Suppl(167:4)","key":"10.1002\/14651858.CD012852.pub2-BIB0016|cit16","first-page":"6","article-title":"Antiphospholipid antibodies and recurrent miscarriage","volume":"76","author":"Rai","year":"1997","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0017|cit17","first-page":"25","article-title":"Prospective randomized trial of aspirin versus aspirin + heparin in pregnant women with a history of recurrent miscarriage in association with antiphospholipid antibodies","volume":"11","author":"Rai","year":"1996","journal-title":"Human Reproduction"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012852.pub2-BIB0018|cit18","first-page":"5","article-title":"Prospective randomised trial of aspirin versus aspirin plus heparin in pregnant women with the antiphospholipid syndrome [abstract]","volume":"93","author":"Rai","year":"1996","journal-title":"British Journal of Haematology"},{"issue":"8","key":"10.1002\/14651858.CD012852.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","article-title":"Treatment of antiphospholipid antibody syndrome (aps) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin","volume":"26","author":"Stephenson","year":"2004","journal-title":"Journal of Obstetrics & Gynaecology Canada: JOGC"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0020|cit20","unstructured":"Agarwal N Screening for inherited thrombophilia in recurrent pregnancy loss and role of therapy with aspirin and low molecular weight heparin (LMWH) ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=22008"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD012852.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","article-title":"A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy","volume":"182","author":"Branch","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0022|cit22","first-page":"73","article-title":"Clinical observation 40 autoimmune habitual abortion patients with low molecular weight heparin calcium","volume":"4","author":"Bu","year":"2009","journal-title":"China Practical Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012852.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.12891\/ceog1904.2015","article-title":"Recurrent miscarriage associated with antiphospholipid antibodies: prophylactic treatment with low-dose aspirin and fish oil derivates","volume":"32","author":"Carta","year":"2005","journal-title":"Clinical & Experimental Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/oxfordjournals.humrep.a135769","article-title":"Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with iv immunoglobulin","volume":"10","author":"Christiansen","year":"1995","journal-title":"Human Reproduction"},{"issue":"Suppl 10","key":"10.1002\/14651858.CD012852.pub2-BIB0025|cit25","first-page":"1283","article-title":"Longterm follow-up of asa\/p trial participants: no evidence of thrombotic sequelae 20 years after anti-phospholipid-associated recurrent pregnancy loss","volume":"60","author":"Clark","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","article-title":"Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment","volume":"166","author":"Cowchock","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD012852.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0002-9378(97)70409-5","article-title":"Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial","volume":"176","author":"Cowchock","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012852.pub2-BIB0028|cit28","first-page":"143","article-title":"Safety and effectiveness of tinzaparin sodium in the management of recurrent pregnancy loss","volume":"34","author":"Dendrinos","year":"2007","journal-title":"Clinical and Experimental Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012852.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijgo.2008.11.010","article-title":"Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome","volume":"104","author":"Dendrinos","year":"2009","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD012852.pub2-BIB0030|cit30","first-page":"S182","article-title":"Dalteparin versus unfractionated heparin for prophylactic anticoagulation during pregnancy [abstract]","volume":"185","author":"De Veciana","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD012852.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT","volume":"10","author":"Vries","year":"2012","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012852.pub2-BIB0032|cit32","first-page":"435","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset preeclampsia in women with antiphospholipid antibodies","volume":"11","author":"Hoorn","year":"2013","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/IJWH.S193293","article-title":"Timing of initiation of low molecular weight heparin administration in pregnant women with antiphospholipid syndrome: a randomized clinical trial of efficacy and safety","volume":"11","author":"Eid","year":"2019","journal-title":"International Journal of Women's Health"},{"issue":"6","key":"10.1002\/14651858.CD012852.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jsgi.2004.02.007","article-title":"Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy","volume":"11","author":"Ensom","year":"2004","journal-title":"Journal of the Society for Gynecologic Investigation"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0035|cit35","first-page":"276","article-title":"Study of heparin on pregnant woman with recurrent pregnant loss and positive anti-phospholipid antibody","volume":"7","author":"Fu","year":"2004","journal-title":"Chinese Journal of Perinatal Medicine"},{"issue":"9095","key":"10.1002\/14651858.CD012852.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0140-6736(05)78093-4","article-title":"Prevention of early pregnancy loss in autoantibody seropositive women [letter]","volume":"351","author":"Geva","year":"1998","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD012852.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/0961203318776089","article-title":"Preconception antiphospholipid antibodies and risk of subsequent early pregnancy loss","volume":"27","author":"Gibbins","year":"2018","journal-title":"Lupus"},{"issue":"3","key":"10.1002\/14651858.CD012852.pub2-BIB0038|cit38","first-page":"CR132","article-title":"The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies","volume":"12","author":"Goel","year":"2006","journal-title":"Medical Science Monitor"},{"issue":"3","key":"10.1002\/14651858.CD012852.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1471-0528.1998.tb10089.x","article-title":"A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group","volume":"105","author":"Golding","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0038-1653781","article-title":"Use of a low-molecular weight heparin (enoxaparin) or of a phenformin-like substance (moroxydine chloride) in primary early recurrent aborters with an impaired fibrinolytic capacity","volume":"73","author":"Gris","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0041|cit41","first-page":"57","article-title":"Study of heparin on pregnant woman with recurrent pregnant loss and positive anti-phospholipid antibody","volume":"8","author":"Guo","year":"2013","journal-title":"China Practical Medicine"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0042|cit42","unstructured":"Ismail A A randomized clinical trial of using preconceptional enoxaparin and low dose aspirin 81mg in patient with antiphospholipid syndrome (aps) clinicaltrials.gov\/ct2\/show\/record\/NCT01661439"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijgo.2015.09.004","article-title":"Randomized controlled study of pre-conception thromboprophylaxis among patients with recurrent spontaneous abortion related to antiphospholipid syndrome","volume":"132","author":"Ismail","year":"2016","journal-title":"International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0044|cit44","first-page":"327","article-title":"Production of prostacylin and thromboxane in lupus pregnancies: effect of small dose of aspirin","volume":"81","author":"Kaaja","year":"1993","journal-title":"Obstetrics & Gynecology"},{"issue":"17","key":"10.1002\/14651858.CD012852.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012852.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/01443610500443352","article-title":"Anticardiolipin antibodies in Jamaican primiparae","volume":"26","author":"Kahwa","year":"2006","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"7","key":"10.1002\/14651858.CD012852.pub2-BIB0047|cit47","first-page":"1404","article-title":"Comparison of pregnancy outcome between low dose aspirin alone and aspirin plus prednisolone treatment in recurrent spontaneous abortion associated with antiphospholipid antibodies","volume":"40","author":"Kim","year":"1997","journal-title":"Korean Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012852.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJM199707173370302","article-title":"Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss","volume":"337","author":"Laskin","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012852.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000078154","article-title":"Effect of IgG therapy on lymphocyte subpopulations in the peripheral blood of Kuwaiti women experiencing recurrent pregnancy loss","volume":"58","author":"Mahmoud","year":"2004","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0050|cit50","unstructured":"Malathi V Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5-9; Hyderabad, Andhra Pradesh, India 2011 184"},{"issue":"10","key":"10.1002\/14651858.CD012852.pub2-BIB0051|cit51","first-page":"1213","article-title":"Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome","volume":"74","author":"Malinowski","year":"2003","journal-title":"Ginekologia Polska"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD012852.pub2-BIB0052|cit52","first-page":"S163","article-title":"Prednisone does not affect the biophysical score in pregnant women with autoantibodies","volume":"180","author":"Mankuta","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012852.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.mefs.2013.12.004","article-title":"Enoxaparin and aspirin therapy for recurrent pregnancy loss due to anti-phospholipid syndrome (APS)","volume":"19","author":"Mohamed","year":"2014","journal-title":"Middle East Fertility Society Journal"},{"issue":"3","key":"10.1002\/14651858.CD012852.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","article-title":"Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin","volume":"83","author":"Noble","year":"2005","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0055|cit55","unstructured":"Quenby S Farquharson R Ramsden G The obstetric outcome of patients with positive anticardiolipin antibodies: aspirin vs no treatment Proceedings of 26th British Congress of Obstetrics and Gynaecology; 1992 July 7-10; Manchester, UK 1992 443"},{"issue":"1","key":"10.1002\/14651858.CD012852.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1210\/jc.2016-2095","article-title":"Low-dose aspirin and sporadic anovulation in the EAGeR randomized trial","volume":"102","author":"Radin","year":"2017","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0057|cit57","unstructured":"Rai R Steroids and antiphospholipid syndrome - related pregnancy loss clinicaltrials.gov\/ct2\/show\/record\/NCT00180778"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0058|cit58","unstructured":"Saad A Mohamed K Pregnancy outcomes in women with recurrent miscarriage treated with low dose aspirin and unfractionated heparin clinicaltrials.gov\/ct2\/show\/NCT02144064"},{"issue":"4","key":"10.1002\/14651858.CD012852.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/AOG.0000000000001301","article-title":"Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses","volume":"127","author":"Ahrens","year":"2016","journal-title":"Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012852.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-0037-1606384","article-title":"The effects of aspirin in gestation and reproduction (eager) trial: a story of discovery","volume":"35","author":"Connell","year":"2017","journal-title":"Seminars in Reproductive Medicine"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012852.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/j.ajog.2015.10.394","article-title":"Recurrent pregnancy loss in women with and without antiphospholipid antibodies","volume":"214","author":"Gibbins","year":"2016","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD012852.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/ppe.12177","article-title":"Recruitment for longitudinal, randomised pregnancy trials initiated preconception: lessons from the Effects of Aspirin in Gestation and Reproduction trial","volume":"29","author":"Lesher","year":"2015","journal-title":"Paediatric and Perinatal Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD012852.pub2-BIB0063|cit63","first-page":"5","article-title":"Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomized trial","volume":"108","author":"Mone","year":"2015","journal-title":"Irish Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD012852.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/humrep\/dev329","article-title":"Expanded findings from a randomized controlled trial of preconception low-dose aspirin and pregnancy loss","volume":"31","author":"Mumford","year":"2016","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD012852.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/humrep\/dex052","article-title":"Preconception maternal lipoprotein levels in relation to fecundability","volume":"32","author":"Pugh","year":"2017","journal-title":"Human Reproduction"},{"issue":"9","key":"10.1002\/14651858.CD012852.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1172\/JCI82357","article-title":"Sex ratio following preconception low-dose aspirin in women with prior pregnancy loss","volume":"125","author":"Radin","year":"2015","journal-title":"Journal of Clinical Investigation"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD012852.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"S352","DOI":"10.1016\/j.ajog.2012.12.008","article-title":"Randomized clinical trial of preconception low dose aspirin use to improve pregnancy outcomes: EAGeR (Effects of Aspirin in Gestation and Reproduction) trial","volume":"208","author":"Schisterman","year":"2013","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD012852.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1210\/jc.2014-4179","article-title":"Preconception low dose aspirin and time to pregnancy: findings from the EAGER (Effects of Aspirin in Gestation And Reproduction) randomized trial","volume":"100","author":"Schisterman","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0069|cit69","unstructured":"Schisterman EF The effects of aspirin in gestation and reproduction: a multi-center, controlled, double-blind randomized trial clinicaltrials.gov\/ct2\/show\/record\/NCT00467363"},{"issue":"9937","key":"10.1002\/14651858.CD012852.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(14)60157-4","article-title":"Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial","volume":"384","author":"Schisterman","year":"2014","journal-title":"Lancet"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012852.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.fertnstert.2013.07.1706","article-title":"Randomized clinical trial of preconception low dose aspirin use and time-to-pregnancy: The eager trial","volume":"100","author":"Schisterman","year":"2013","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD012852.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/ppe.12088","article-title":"A randomised trial to evaluate the effects of low-dose aspirin in gestation and reproduction: design and baseline characteristics.[Erratum appears in Paediatr Perinat Epidemiol. 2014 May;28(3):275]","volume":"27","author":"Schisterman","year":"2013","journal-title":"Paediatric and Perinatal Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012852.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/AOG.0000000000000736","article-title":"Low-dose aspirin and preterm birth: a randomized controlled trial","volume":"125","author":"Silver","year":"2015","journal-title":"Obstetrics and Gynecology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012852.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/j.fertnstert.2015.07.1086","article-title":"Preconception low dose aspirin treatment improves clinical pregnancy and live birth in women with higher systemic inflammation","volume":"104","author":"Sjaarda","year":"2015","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD012852.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1210\/jc.2016-2917","article-title":"Preconception low-dose aspirin restores diminished pregnancy and live birth rates in women with low grade inflammation: a secondary analysis of a randomized trial","volume":"102","author":"Sjaarda","year":"2017","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0076|cit76","unstructured":"Shefras J Farquharson RG Heparin therapy, bone density and pregnancy 27th British Congress of Obstetrics and Gynaecology; 1995 July 4-7;-Dublin, Ireland 1995 93"},{"issue":"6","key":"10.1002\/14651858.CD012852.pub2-BIB0077|cit77","first-page":"414","article-title":"Clinical observation on effect of Chinese herbal medicine plus human chorionic gonadotropin and progesterone in treating anticardiolipin antibody-positive early recurrent spontaneous abortion","volume":"22","author":"Shu","year":"2002","journal-title":"Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi\/\/Chinese Journal of Integrated Traditional and Western Medicine"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/0002-9378(93)90410-K","article-title":"Comparative trial of prednisone plus aspirin vs aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients","volume":"169","author":"Silver","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"#cr-split#-10.1002\/14651858.CD012852.pub2-BIB0079|cit79.1","unstructured":"Silver RK Sholl JS MacGregor SN Hobart JH Neerhof MG Hickman AH Prospective evaluation of single (low-dose aspirin) vs combined (aspirin plus prednisone) therapy in the treatment of the antiphospholipid syndrome Proceedings of 39th Annual Meeting of the Society for Gynecologic Investigation 1992 March 18-21"},{"key":"#cr-split#-10.1002\/14651858.CD012852.pub2-BIB0079|cit79.2","unstructured":"San Antonio, Texas, USA 1992 125"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0080|cit80","first-page":"1314","article-title":"Effect of low molecular weight heparin combined with low-dose aspirin for ACA positive recurrent spontaneous abortion","volume":"23","author":"Tang","year":"2012","journal-title":"Hainan Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD012852.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/art.10957","article-title":"Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies","volume":"48","author":"Triolo","year":"2003","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD012852.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/humrep\/12.Suppl_2.191","article-title":"Low dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production","volume":"12","author":"Tulppala","year":"1997","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/humrep\/12.7.1567","article-title":"Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production","volume":"12","author":"Tulppala","year":"1997","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0084|cit84","first-page":"S203","article-title":"The effect of acetyl salicylic acid and prednisolone before and during pregnancy in reducing unexplained recurrent abortions","volume":"72","author":"Vahid Dastjerdi","year":"1999","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejogrb.2015.12.011","article-title":"Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT","volume":"197","author":"Hoorn","year":"2016","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD012852.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.8755-8920.2001.450309.x","article-title":"Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin","volume":"45","author":"Vaquero","year":"2001","journal-title":"American Journal of Reproductive Immunology"},{"issue":"2","key":"10.1002\/14651858.CD012852.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH10-05-0334","article-title":"Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia - HABENOX*: a randomised multicentre trial","volume":"105","author":"Visser","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD012852.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3892\/etm.2012.743","article-title":"Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome","volume":"5","author":"Xiao","year":"2013","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0089|cit89","first-page":"60","article-title":"The effect of aspirin combined with low molecular weight heparin in treatment of 30 patients with habitual abortion and antiphospholipid syndrome","volume":"50","author":"Zhou","year":"2012","journal-title":"China Modern Doctor"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0090|cit90","unstructured":"Abdelhafez M Use of warfarin after the first trimester in pregnant women with antiphospholipid syndrome clinicaltrials.gov\/ct2\/show\/record\/NCT02303171"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0091|cit91","unstructured":"Rodger M A pilot study assessing the feasibility of a randomized controlled trial evaluating aspirin versus low-molecular-weight heparin (lmwh) and aspirin in women with antiphospholipid syndrome and pregnancy loss clinicaltrials.gov\/ct2\/show\/NCT03100123"},{"issue":"6","key":"10.1002\/14651858.CD012852.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/01.AOG.0000423816.39542.0f","article-title":"Practice Bulletin No. 132: Antiphospholipid syndrome","volume":"120","author":"Committee on Practice Bulletins - American College of Obstetricians and Gynecologists","year":"2012","journal-title":"Obstetrics and Gynecology"},{"issue":"9575","key":"10.1002\/14651858.CD012852.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0094|cit94","first-page":"e691S-e736S","article-title":"VTE, Thrombophilia, AntithromboticTherapy, and Pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Advances"},{"issue":"6","key":"10.1002\/14651858.CD012852.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","article-title":"Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy","volume":"30","year":"2009","journal-title":"Placenta"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"Buyon","year":"2015","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/9780203931677","volume-title":"Recurrent Pregnancy Loss, Causes, Controversies and Treatment","author":"Carp","year":"2007"},{"issue":"18","key":"10.1002\/14651858.CD012852.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"14961","DOI":"10.1074\/jbc.M011550200","article-title":"Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin","volume":"276","author":"Chuang","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood-2017-05-781971","article-title":"Thrombocytopenia in pregnancy","volume":"130","author":"Cines","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD012852.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/j.1538-7836.2010.04015.x","article-title":"Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy","volume":"8","author":"Cohn","year":"2010","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"7","key":"10.1002\/14651858.CD012852.pub2-BIB0102|cit102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004734.pub4","article-title":"Aspirin and\/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia","author":"Jong","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0103|cit103","unstructured":"Deeks JJ Higgins JP Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jri.2006.12.003","article-title":"The obstetric antiphospholipid syndrome","volume":"77","author":"Derksen","year":"2008","journal-title":"Journal of Reproductive Immunology"},{"issue":"1","key":"10.1002\/14651858.CD012852.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P","article-title":"Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adheredbeta2-glycoprotein I","volume":"43","author":"Di Simone","year":"2000","journal-title":"Arthritis Rheumatology"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0106|cit106","first-page":"17","volume-title":"Antiphospholipid Syndrome in Systemic Autoimmune Diseases","author":"Durcan","year":"2016"},{"issue":"8","key":"10.1002\/14651858.CD012852.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/41.8.924","article-title":"A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome","volume":"41","author":"Erkan","year":"2002","journal-title":"Rheumatology"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012852.pub2-BIB0109|cit109","first-page":"89","article-title":"Low molecular weight heparin: a critical analysis of clinical trials","volume":"46","author":"Green","year":"1994","journal-title":"Pharmacological Reviews"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2014.01.006","article-title":"Diagnosis and classification of the antiphospholipid syndrome","volume":"48-49","author":"G\u00f3mez-Puerta","year":"2014","journal-title":"Journal of Autoimmunity"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0111|cit111","unstructured":"Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology Cochrane Database of Systematic Reviews 2019 11 10.1002\/14651858.CD003511.pub5"},{"issue":"8361","key":"10.1002\/14651858.CD012852.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(83)91267-9","article-title":"Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupuserythematosus","volume":"322","author":"Harris","year":"1983","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0114|cit114","unstructured":"Higgins JP Altman DG Churchill R Chandler J Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/0961203309360544","article-title":"Domain I of beta2-glycoprotein I: its role as an epitope and the potential to be developed as a specific target for the treatment of the antiphospholipid syndrome","volume":"19","author":"Ioannou","year":"2010","journal-title":"Lupus"},{"issue":"9","key":"10.1002\/14651858.CD012852.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1538-7836.2011.04401.x","article-title":"Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin","volume":"9","author":"Kozlowski","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"7","key":"10.1002\/14651858.CD012852.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1002\/14651858.CD012852.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cll.2013.01.001","article-title":"Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy","volume":"33","author":"Lockshin","year":"2013","journal-title":"Clinics in Laboratory Medicine"},{"issue":"9","key":"10.1002\/14651858.CD012852.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","article-title":"Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance","volume":"112","author":"Love","year":"1990","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012852.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/0961203312438116","article-title":"Obstetric and vascular APS: same autoantibodies but different diseases?","volume":"21","author":"Meroni","year":"2012","journal-title":"Lupus"},{"issue":"7","key":"10.1002\/14651858.CD012852.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41584-018-0032-6","article-title":"Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?","volume":"14","author":"Meroni","year":"2018","journal-title":"Nature Reviews Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD012852.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"7","key":"10.1002\/14651858.CD012852.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLOS Medicine"},{"issue":"8812","key":"10.1002\/14651858.CD012852.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0140-6736(92)93223-A","article-title":"Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis","volume":"340","author":"Nurmohamed","year":"1992","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/j.thromres.2009.11.030","article-title":"Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy","volume":"125","author":"Oberkersch","year":"2010","journal-title":"Thrombosis Research"},{"issue":"11","key":"10.1002\/14651858.CD012852.pub2-BIB0126|cit126","first-page":"2214","article-title":"Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis","volume":"33","author":"Opatrny","journal-title":"Journal of Rheumatology"},{"issue":"11","key":"10.1002\/14651858.CD012852.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"e1002160","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLOS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012852.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"e12785","DOI":"10.1111\/aji.12785","article-title":"Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies","volume":"79","author":"Quao","year":"2018","journal-title":"American Journal of Reproductive Immunology"},{"issue":"10","key":"10.1002\/14651858.CD012852.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/oxfordjournals.humrep.a136224","article-title":"Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach","volume":"8","author":"Rai","year":"1995","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD012852.pub2-BIB0130|cit130","first-page":"3453","article-title":"Neutrophil activation by the tissue factor\/Factor VIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome","volume":"118","author":"Redecha","year":"2008","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0131|cit131","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2013-01-478958","article-title":"Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications","volume":"123","author":"Rodger","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD012852.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"9751","key":"10.1002\/14651858.CD012852.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD012852.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.semarthrit.2012.01.001","article-title":"The role of complement in the antiphospholipid syndrome: a novel mechanism for pregnancy morbidity","volume":"42","author":"Samarkos","year":"2012","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.blre.2018.08.001","article-title":"Everything the clinician needs to know about evidence-based anticoagulation in pregnancy","volume":"33","author":"Scheres","year":"2019","journal-title":"Blood Reviews"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"18005","DOI":"10.1038\/nrdp.2018.5","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.thromres.2015.11.026","article-title":"Microvesicles of pregnant women receiving low molecular weight heparin improve trophoblast function","volume":"137","author":"Shomer","year":"2016","journal-title":"Thrombosis Research"},{"issue":"13","key":"10.1002\/14651858.CD012852.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2015-12-626739","article-title":"A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia","volume":"127","author":"Skeith","year":"2016","journal-title":"Blood"},{"issue":"21","key":"10.1002\/14651858.CD012852.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1182\/blood-2018-05-848697","article-title":"Anticoagulating patients with high-risk acquired thrombophilias","volume":"132","author":"Skeith","year":"2018","journal-title":"Blood"},{"issue":"25","key":"10.1002\/14651858.CD012852.pub2-BIB0141|cit141","first-page":"232","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nature: New Biology"},{"issue":"5-6","key":"10.1002\/14651858.CD012852.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thrombosis Research"},{"issue":"2","key":"10.1002\/14651858.CD012852.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"hoy004","DOI":"10.1093\/hropen\/hoy004","article-title":"ESHRE guideline: recurrent pregnancy loss","volume":"2018","author":"Bender Atik","year":"2018","journal-title":"Human Reproduction Open"},{"issue":"2","key":"10.1002\/14651858.CD012852.pub2-BIB0144|cit144","first-page":"207","article-title":"Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties","volume":"91","author":"Vignoli","year":"2006","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD012852.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/jth.14191","article-title":"Molecular actions of heparin and their implications in preventing pre-eclampsia","volume":"16","author":"Wat","year":"2018","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD012852.pub2-BIB0146|cit146","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002859.pub2","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","author":"Empson","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD012852.pub2-BIB0147|cit147","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012852","article-title":"Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss","author":"Scheres","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T09:03:33Z","timestamp":1686387813000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012852.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,2]]},"references-count":148,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012852.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,2]]}}}